Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...
The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHD NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharm ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
FDA’s PDUFA goal date is November 1, 2026; If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease; CAMBRIDGE, Mass., Ju ...
Holistic hybrid health begins from the inside out. It is nurtured from the outside in with attention to our behavior, ...
Depriving yourself of sleep by going to bed even an hour or two later than you should may contribute to weight gain over time ...
FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Many people use glucosamine, though evidence of its effectiveness is mixed at best, experts said.
While this “no pain, no gain” mindset may work in the short-term, science is clear that it doesn’t work long-term. According ...
The final set of your workout is about to get a lot more interesting.
Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...
Study participants who drank 5 or more cups of coffee per day had a 32% lower risk of developing cirrhosis, and an almost 50% lower risk of liver cancer, the findings showed.